Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Latour

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Presse Medicale (Paris, France : 1983)|January 10, 2001
[Standards, options, and recommendations for the use of hematopoietic growth factors in oncology]J Y Blay, A Le Cesne, M P Blanc-Vincent, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 23, 2011
The PhaSeal® system: impact of its use on workplace contamination and duration of chemotherapy preparationB Favier, H Labrosse, L Gilles-Afchain, et al.
Bulletin Du Cancer|October 20, 2000
[Huriet law: application in a regional cancer centre (Centre Léon-Bérard, Lyon)]G Chvetzoff, I Ray-Coquard, A Dumortier, et al.
Bulletin Du Cancer|August 22, 2009
[Improvement of quality of practices for the preparation of cytotoxic drugs: results of a "before-after" study]L Gilles, B Favier, F Catillon, et al.
Presse Medicale (Paris, France : 1983)|June 11, 1988
[Hemoperfusion on charcoal and hemodialysis in acute poisoning caused by methotrexate]D Frappaz, E Bouffet, P Cochat, et al.
Annales Pharmaceutiques Francaises|May 3, 2015
[Study impacto: Descriptive analyzis of pharmacist's clinical practice in onco-hematology]R Le Guen, I Madelaine, J-F Tournamille, et al.
Clinical Nutrition (Edinburgh, Scotland)|April 17, 1999
Energy expenditure during allogeneic and autologous bone marrow transplantationV Chamouard Cogoluenhes, C Chambrier, M Michallet, et al.
Bulletin Du Cancer|January 26, 1999
[Analysis of hematopoietic growth factor prescriptions in 19 french cancer centers]L Gautié, P Canal, A Menguy, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Presse Medicale (Paris, France : 1983)|January 10, 2001
[Standards, options, and recommendations for the use of hematopoietic growth factors in oncology]J Y Blay, A Le Cesne, M P Blanc-Vincent, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 23, 2011
The PhaSeal® system: impact of its use on workplace contamination and duration of chemotherapy preparationB Favier, H Labrosse, L Gilles-Afchain, et al.
Bulletin Du Cancer|October 20, 2000
[Huriet law: application in a regional cancer centre (Centre Léon-Bérard, Lyon)]G Chvetzoff, I Ray-Coquard, A Dumortier, et al.
Bulletin Du Cancer|August 22, 2009
[Improvement of quality of practices for the preparation of cytotoxic drugs: results of a "before-after" study]L Gilles, B Favier, F Catillon, et al.
Presse Medicale (Paris, France : 1983)|June 11, 1988
[Hemoperfusion on charcoal and hemodialysis in acute poisoning caused by methotrexate]D Frappaz, E Bouffet, P Cochat, et al.
Annales Pharmaceutiques Francaises|May 3, 2015
[Study impacto: Descriptive analyzis of pharmacist's clinical practice in onco-hematology]R Le Guen, I Madelaine, J-F Tournamille, et al.
Clinical Nutrition (Edinburgh, Scotland)|April 17, 1999
Energy expenditure during allogeneic and autologous bone marrow transplantationV Chamouard Cogoluenhes, C Chambrier, M Michallet, et al.
Bulletin Du Cancer|January 26, 1999
[Analysis of hematopoietic growth factor prescriptions in 19 french cancer centers]L Gautié, P Canal, A Menguy, et al.
Pageof 2